AeroVironment (AVAV) Reports Next Week: Wall Street Expects Earnings Growth

AeroVironment is expected to report fiscal-quarter results on December 9 with Zacks consensus EPS of $0.85 (up 80.9% y/y) and revenue of $477.43 million (up 153.3% y/y). Consensus EPS was revised down 1.59% over 30 days and the Most Accurate Estimate sits below consensus, producing a negative Earnings ESP of -9.20%; the stock carries a Zacks Rank #3. Last quarter the company missed consensus by ~5.9% (reported $0.32 vs $0.34 expected) and has beaten consensus only once in four quarters, so while headline growth expectations are strong, the data imply limited odds of an upside surprise and management commentary will be key for near-term stock direction.

Analysis

Market structure: AVAV sits in the small-cap tactical UAS segment where wins are binary — large single contracts or government order timing drive quarters. Winners if results confirm sustainable backlog growth: primes (LMT, RTX) and specialty subsystems suppliers who can scale; losers are fellow small-cap UAV pure-plays that lose scarce DoD wallet share. Expect pricing power to remain with vendors that convert large PO flow into recurring sustainment revenue; a one-quarter revenue spike (consensus +153% YoY) suggests lumpy recognition rather than durable margin expansion.

Risk assessment: Near-term (days) the biggest risk is an EPS/guide miss on Dec 9 causing >10–20% gap down; short-term (1–3 months) risks include contract timing, backlog disclosures and margin compression from pass-through costs; long-term (1–3 years) regulatory export controls, program cancellations, or DoD budget shifts could reduce TAM by >20%. Hidden dependencies: revenue recognition cadence, single-customer concentration, and supply-chain phasing; key catalysts are earnings, any announced awards or cancellations, and DoD funding headlines.

Trade implications: Avoid building a material (>2–3%) outright long before earnings. If selective exposure desired, buy a defined-risk put spread 10–20% OTM into the Dec expiry (30–45 days) to hedge event risk or to express a tactical bearish view; alternatively enter a relative-value pair: short AVAV (notional 1%) vs long ITA (iShares U.S. Aerospace & Defense ETF) (notional 1.5%) to isolate idiosyncratic downside. Post-earnings, if AVAV sells off >20% on no deterioration in backlog or guidance, consider accumulating a 2–4% position for a 12–36 month horizon.

Contrarian angles: The consensus underweights that a strong print could be driven by non-repeatable milestone revenue — if management converts backlog into multi-year sustainment guidance the stock could rally >30% quickly; conversely the market may over-penalize a miss if backlog remains intact. Historical parallels: small defense-cap wins (one-off contract recognition) often produce sharp volatile repricings rather than linear fundamentals shifts. Action should therefore be event-driven and threshold-based (e.g., buy on >20% dislocation or on upgraded multi-year backlog guidance).

Key Decisions for Investors

• Do not initiate >2% long position in AVAV ahead of the Dec 9 earnings release; risk of a negative EPS surprise is elevated (Earnings ESP -9.2%).
• Establish a defined-risk bearish options trade: buy Dec (30–45 day) put spread 10–20% OTM with a max loss equal to premium to capture expected post-earnings volatility — target payoff if AVAV drops 10–25%.
• Implement a relative-value pair: short AVAV (notional 1% portfolio) vs long ITA (iShares U.S. Aerospace & Defense ETF) (notional 1.5%) to hedge sector exposure and isolate idiosyncratic downside through 90 days.
• Post-earnings entry: if AVAV sells off >20% on an earnings miss but discloses backlog growth or unchanged multi-year guidance, scale into a 2–4% long position with a 12–36 month horizon (target 30–50% upside if backlog converts).
• Monitor within 7 days post-earnings for three specific metrics before adding exposure: reported backlog change (%) vs prior quarter, FY24/25 revenue guidance delta (±10% threshold), and margin guidance — any upgrade on two of three warrants re-evaluation to add exposure.